MON-277 Patient Health Questionnaire 9 (PHQ-9) and Barrat Impulsivity Scale (BIS-11); Tools to Identify Side Effects of Dopamine Agonist Treatment in Patients with Pituitary Adenomas

Background There is augmented concern for dopamine agonists (DA) related risk to mood and impulse control disorders (ICD) in patients (pts) with pituitary adenomas (PA). In this study, we analyzed prevalence using two validated self-assessment screening surveys; PHQ-9 and BIS-11. Methods A retrospec...

Descripción completa

Detalles Bibliográficos
Autores principales: Hinojosa-Amaya, José Miguel, Johnson, Nathaniel, Varlamov, Elena V, González-Torres, Christine, Yedinak, Christina G, McCartney, Shirley, Fleseriu, Maria
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2020
Materias:
Neuroendocrinology and Pituitary
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7208366/
http://dx.doi.org/10.1210/jendso/bvaa046.978

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7208366/
http://dx.doi.org/10.1210/jendso/bvaa046.978

Ejemplares similares